7Baggers

We provide you with 20 years of free, institutional-grade data for ASRT stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ASRT. Explore the full financial landscape of ASRT stock.

Reported DateCIKTickerType
2024-05-061808665ASRT10-QUrl
2024-03-111808665ASRT10-KUrl
2023-11-081808665ASRT10-QUrl
2023-08-091808665ASRT10-QUrl
2023-05-091808665ASRT10-QUrl
2023-03-081808665ASRT10-KUrl
2022-11-081808665ASRT10-QUrl
2022-08-081808665ASRT10-QUrl
2022-05-091808665ASRT10-QUrl
2022-03-101808665ASRT10-KUrl
2021-11-041808665ASRT10-QUrl
2021-08-051808665ASRT10-QUrl
2021-05-061808665ASRT10-QUrl
2021-03-121808665ASRT10-KUrl
2020-11-061808665ASRT10-QUrl
2020-08-101808665ASRT10-QUrl

Assertio Holdings Inc
(NASDAQ:ASRT) 

ASRT stock logo

Assertio Holdings, Inc., a commercial pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. The company's pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis...

Founded: 1995
Full Time Employees: 125
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic

Share this website to your friends
The information provided in this report about ASRT stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.